A retrospective study on long-term efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease

PURPOSE: Aspirin treatment after desensitization (ATAD) represents an effective therapeutic option suitable for NSAID-exacerbated respiratory disease (N-ERD) patients with recalcitrant disease. Intranasal administration of lysine-aspirin (LAS) has been suggested as a safer and faster route than oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Pendolino, Alfonso Luca, Scadding, Glenis K., Scarpa, Bruno, Andrews, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Rhinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986745/
https://www.ncbi.nlm.nih.gov/pubmed/34480600
http://dx.doi.org/10.1007/s00405-021-07063-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986745/
https://www.ncbi.nlm.nih.gov/pubmed/34480600
http://dx.doi.org/10.1007/s00405-021-07063-2

Ejemplares similares